Live Breaking News & Updates on Susan Passalaqua

Stay updated with breaking news from Susan passalaqua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pivotal Phase 3 SIERRA Trial Data Showing 100% Bone Marrow Transplant Engraftment in Patients Treated with Iomab-B presented at the 2021 Virtual SNMMI Conference

Pivotal Phase 3 SIERRA Trial Data Showing 100% Bone Marrow Transplant Engraftment in Patients Treated with Iomab-B presented at the 2021 Virtual SNMMI Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Susan Passalaqua , Hans Vitzthum , Mark Berger , Company Phase , Lifesci Advisors , Exchange Commission , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , Banner Md Anderson Cancer Center , Society Of Nuclear Medicine , Memorial Sloan Kettering Cancer Center , Actinium Pharmaceuticals , Nuclear Medicine , Molecular Imaging , Annual Meeting , Chief Medical Officer , Marrow Radiation Dose , Active Relapsed , Refractory Acute Myeloid , Conventional Care , Crossed Over , Therapeutic Dose , Marrow Blast , Post Randomization , Dose Delivered , Relapse Transplant Related ,

Actinium Announces Several Presentations from the Phase 3 SIERRA Study of Iomab-B at the SNMMI 2021 Virtual Annual Meeting

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that three abstracts highlighting data and. ....

United Kingdom , Roberto Fedrigo , Susan Passalaqua , Sandesh Seth , Hans Vitzthum , Mark Berger , Lifesci Advisors , Exchange Commission , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , University Of British Columbia , Banner Md Anderson Cancer Center , Society Of Nuclear Medicine , Memorial Sloan Kettering Cancer Center , Bc Cancer Research Institute , Actinium Pharmaceuticals , Nuclear Medicine , Molecular Imaging , Chief Medical Officer , Presentation Title , Marrow Radiation Dose , Active Relapsed , Refractory Acute Myeloid , Incidence Rates , Febrile Neutropenia , Randomized Phase ,